NEXUS GLOBAL GROUP
LIVE

Serial Number

99638532

Owner

Vaniam Group LLC

Attorney

Matthew J. Gryzlo

Filing Date

Feb 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NEXUS GLOBAL GROUP Trademark

Serial Number: 99638532

NEXUS GLOBAL GROUP is a trademark filed by Vaniam Group LLC on February 6, 2026. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Vaniam Group LLC (11 trademarks)

1444 N. Orleans St., Suite 8K
Chicago, IL 60610

Entity Type: 16

Trademark Details

Filing Date

February 6, 2026

Registration Date

Not Registered

Goods & Services

Providing information about legal eligibility requirements for government medical and pharmaceutical programs; Regulatory compliance consultancy in the field of pharmaceuticals

Scientific research consulting; Technical consulting in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Consulting services in the field of pharmaceutical research and development; Providing medical research information in the field of pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials

Arranging, conducting and organization of seminars, lecture presentations and symposiums for internal training; Arranging and conducting of lectures in the field of healthcare and pharmaceuticals; Providing classes, seminars, workshops, presentations and retreats in the field of health; Consultancy relating to arranging and conducting of congresses; Consultancy relating to arranging and conducting of conferences; Arranging and conducting of conferences and symposia in the field of medical science; Business training; Arranging and conducting of training seminars in the field of pharmaceutical research; Writing of articles for professional journals other than for advertising or publicity

New product commercialization services; Competitive intelligence services; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Business consultation and management regarding marketing activities and launching of new products; Brand positioning services; Business strategy development services; Marketing and branding services, namely, providing customized communication programs to obtain consumer insights and develop branding strategies; Marketing services; Marketing consulting; Marketing advisory services; Digital marketing services; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others; Consultancy regarding advertising communication strategies; Creative marketing plan development services; Creating and updating advertising material; Public relations; Public relations consultancy; Media relations services; Consulting in sales techniques and sales programs; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Consulting services in the field of medical product approval for commercial purposes; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of pharmaceutical development; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Organizing business networking events in the field of pharmaceuticals; Organizing exhibitions for commercial or advertising purposes

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 6, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2026 NWOS
NEW APPLICATION ENTERED
Feb 6, 2026 NWAP